Filter Results:
(924)
Show Results For
- All HBS Web
(924)
- People (2)
- News (70)
- Research (773)
- Events (1)
- Multimedia (2)
- Faculty Publications (664)
Show Results For
- All HBS Web
(924)
- People (2)
- News (70)
- Research (773)
- Events (1)
- Multimedia (2)
- Faculty Publications (664)
- 25 Jun 2020
- News
Covering All Corners
Riad Armanious (MBA 2008) regards the pandemic as the greatest professional challenge he has faced as managing director of family-owned Eva Group and CEO of Eva Pharma, a multinational pharmaceutical company headquartered in Egypt. The... View Details
- 28 Mar 2023
- Blog Post
Novo Nordisk
learned details of how Novo Nordisk manufactures within its 1,200,000 square meter facility high-quality active pharmaceutical ingredients (APIs) that tackle not only diabetes but also hemophilia, growth disorders, and obesity. At their... View Details
- 01 Feb 2001
- News
Drilling Down
The news last October of Chevron's proposed acquisition of Texaco for $36 billion in stock was hardly surprising to industry analysts. The planned merger — which would streamline projects and save some $1.2 billion annually — was... View Details
- 13 Jan 2003
- Research & Ideas
Making Biotech Work as a Business
influenced the industry by proving that intellectual property could be monetized through alliances with big pharmaceutical partners, according to Pisano. Genentech cut its first deal with Eli Lilly in 1982... View Details
- 29 May 2001
- Research & Ideas
Genomics: Can We Start Making Money Now?
don't survive clinical trials, resulting in the pharmaceutical industry footing enormous bills for failure. Genomics will be a productivity driver, pushing perhaps a 100 percent increase in drug development,... View Details
Keywords: by Sean Silverthorne
- 07 Apr 2003
- Research & Ideas
Three Steps for Crisis Prevention
challenges, not on the hard work of winning hearts and minds, Shapiro ultimately lost his company. He was forced to sell Monsanto to Pharmacia-Upjohn, which bought it for its pharmaceutical division, valuing the agricultural biotechnology... View Details
Keywords: by Michael D. Watkins & Max H. Bazerman
- 15 Dec 2024
- News
After Ozempic
Back before Ozempic, when Kate Mulroney (MBA 1984) spoke at technical conferences about her work at Novo Nordisk, people often assumed she was talking about Novartis. “I’d have to explain that’s a Swiss company; we’re Danish,” says Mulroney, now head of advanced... View Details
- 01 Dec 1996
- News
New Releases
computer industries, in which interfirm and international rivalries are intense. The other three consortia - Electric Power Research Institute (EPRI), Gas Research Institute (GRI), and Bell Communications Research (Bellcore) - draw their membership from regulated View Details
- 01 Sep 2010
- News
Fair Trade
pharmaceuticals and software, and far above the average of all industries. Many apparent paradoxes add to the puzzle posed by the industry. While rarely considered fundamentally “bad,” such as the trade in narcotics or tobacco, the beauty... View Details
- 13 Feb 2006
- Research & Ideas
The Hidden Market for Babies
working on? A: I'm working on several cases right now, most of which deal with the pharmaceutical industry and the ways in which pharmaceutical firms manage through the... View Details
- 15 Sep 2009
- First Look
First Look: September 15
innovations. Ceteris paribus, the share of resources spent on development of general innovations, increases with the stability of the market share of the industry leader. As market shares become less persistent, the model predicts an... View Details
Keywords: Martha Lagace
- 01 Mar 2009
- News
A New Approach to Health-Care Reform
they know what disruptive innovation means, but I’ve found it’s often misunderstood. The simplest way to describe it — in a way that applies to health care or any industry — is innovation that transforms a product or service that... View Details
- 01 May 2007
- First Look
First Look: May 1, 2007
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=207113 Strategy in the 21st Century Pharmaceutical Industry: Merck & Co. and Pfizer Inc. Harvard Business School Case 707-509 The global View Details
Keywords: Sean Silverthorne
- 23 Jun 2003
- Research & Ideas
Historically Speaking: A Roundtable at HBS
States, Europe, and Japan, it was supposed to examine two sectors: first, the chemical and pharmaceutical industries, which helped bring about the Second Industrial Revolution between the 1880s and 1920s,... View Details
Keywords: by Jim Aisner
- Profile
Paul Wang
work with the MIT’s Abdul Latif Jameel Poverty Action Lab (J-PAL). “They’re a group of economists who use randomized evaluation methodologies, similar to those used in pharmaceutical trials, to assess the impact of development projects,”... View Details
- 01 Dec 2020
- News
The Complete Package
school, she got a job in a hotel sales department and decided to defer her education. Two years later, Pfizer headhunted Chong. She didn’t know the number of chambers in the heart, she admitted during her interview with the pharmaceutical... View Details
Keywords: April White; entrepreneurship; sustainability; packaging; leadership; women; Manufacturing
- Fast Answer
Transforming Health Care Delivery
href="http://www.library.hbs.edu/go/guidestar.html" target="_blank">GuideStar Pro - Information about the missions, programs, and finances of more than 1.7 million nonprofit organizations. View Details
- Profile
Thomas Grenier
as well. Through coursework and networking opportunities during my HBS experience, I received a lot of career advice, learned key industry knowledge, made contacts and, most importantly, came to appreciate everyone's passion for what they... View Details
- 01 Mar 2003
- News
Inside the Revolution
humanity discovered how to use fire,” says Enriquez’s colleague, HBS associate professor Jonathan West. West, who had been researching the semiconductor industry for some ten years, came to the life sciences field rather recently.... View Details
- 17 Mar 2009
- First Look
First Look: March 17, 2009
Agreements in Bio-Pharmaceuticals Authors:Juan Alcácer, John Cantwell, and Michelle Gittelman Publication:In Location of Biopharmaceutical Activity, edited by Iain M. Cockburn and Matthew J. Slaughter. NBER, forthcoming. Abstract As the value chain of the View Details
Keywords: Martha Lagace